283 related articles for article (PubMed ID: 29786783)
21. Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression.
Hu HT; Huang YH; Chang YA; Lee CK; Jiang MJ; Wu LW
J Invest Dermatol; 2008 Sep; 128(9):2325-33. PubMed ID: 18401423
[TBL] [Abstract][Full Text] [Related]
22. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW
Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340
[TBL] [Abstract][Full Text] [Related]
23. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.
Hori Y; Hirose K; Aramaki-Hattori N; Suzuki S; Nakayama R; Inoue M; Matsui T; Kohara M; Toyosawa S; Morii E
Diagn Pathol; 2020 Jul; 15(1):98. PubMed ID: 32711543
[TBL] [Abstract][Full Text] [Related]
24. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations.
Morris PN; Dunmore BJ; Tadros A; Marchuk DA; Darland DC; D'Amore PA; Brindle NP
J Mol Med (Berl); 2005 Jan; 83(1):58-63. PubMed ID: 15526080
[TBL] [Abstract][Full Text] [Related]
25. Venous malformation vessels are improperly specified and hyperproliferative.
Schonning MJ; Koh S; Sun RW; Richter GT; Edwards AK; Shawber CJ; Wu JK
PLoS One; 2021; 16(5):e0252342. PubMed ID: 34043714
[TBL] [Abstract][Full Text] [Related]
26. Somatic TEK variant with intraarticular venous malformation and knee hemarthrosis treated with rapamycin.
Adham S; Revencu N; Mestre S; Nou-Howaldt M; Vernhet-Kovacsik H; Quéré I
Mol Genet Genomic Med; 2022 Jun; 10(6):e1931. PubMed ID: 35426265
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.
Limaye N; Wouters V; Uebelhoer M; Tuominen M; Wirkkala R; Mulliken JB; Eklund L; Boon LM; Vikkula M
Nat Genet; 2009 Jan; 41(1):118-24. PubMed ID: 19079259
[TBL] [Abstract][Full Text] [Related]
28. Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation.
Aw WY; Cho C; Wang H; Cooper AH; Doherty EL; Rocco D; Huang SA; Kubik S; Whitworth CP; Armstrong R; Hickey AJ; Griffith B; Kutys ML; Blatt J; Polacheck WJ
Sci Adv; 2023 Feb; 9(7):eade8939. PubMed ID: 36791204
[TBL] [Abstract][Full Text] [Related]
29. Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations.
Soblet J; Limaye N; Uebelhoer M; Boon LM; Vikkula M
Mol Syndromol; 2013 Apr; 4(4):179-83. PubMed ID: 23801934
[TBL] [Abstract][Full Text] [Related]
30. A Tie2 kinase mutation causing venous malformations increases phosphorylation rates and enhances cooperativity.
Kennedy MA; Xu Z; Wu Y; Sohl CD
Biochem Biophys Res Commun; 2019 Feb; 509(4):898-902. PubMed ID: 30638931
[TBL] [Abstract][Full Text] [Related]
31. Transgenic Expression of A Venous Malformation Related Mutation,
Du Z; Ma HL; Zhang ZY; Zheng JW; Wang YA
Int J Med Sci; 2018; 15(4):385-394. PubMed ID: 29511374
[TBL] [Abstract][Full Text] [Related]
32. Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.
Uebelhoer M; Nätynki M; Kangas J; Mendola A; Nguyen HL; Soblet J; Godfraind C; Boon LM; Eklund L; Limaye N; Vikkula M
Hum Mol Genet; 2013 Sep; 22(17):3438-48. PubMed ID: 23633549
[TBL] [Abstract][Full Text] [Related]
33. Association study between of Tie2/angiopoietin-2 and VEGF/KDR pathway gene polymorphisms and vascular malformations.
Zheng Q; Du J; Zhang Z; Xu J; Fu L; Cao Y; Huang X; Guo L
Gene; 2013 Jul; 523(2):195-8. PubMed ID: 23566851
[TBL] [Abstract][Full Text] [Related]
34. Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.
Chen G; Ren JG; Zhang W; Sun YF; Wang FQ; Li RF; Zhang J; Zhao YF
Sci Rep; 2014 Jun; 4():5457. PubMed ID: 24966004
[TBL] [Abstract][Full Text] [Related]
35. The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.
Kobialka P; Sabata H; Vilalta O; Gouveia L; Angulo-Urarte A; Muixí L; Zanoncello J; Muñoz-Aznar O; Olaciregui NG; Fanlo L; Esteve-Codina A; Lavarino C; Javierre BM; Celis V; Rovira C; López-Fernández S; Baselga E; Mora J; Castillo SD; Graupera M
EMBO Mol Med; 2022 Jul; 14(7):e15619. PubMed ID: 35695059
[TBL] [Abstract][Full Text] [Related]
36. Venous malformations: PIK3CA mutations guide new treatments.
Dbouk HA
Oncotarget; 2016 Aug; 7(31):48852-48853. PubMed ID: 27447853
[No Abstract] [Full Text] [Related]
37. Targeted therapy for capillary-venous malformations.
Zerbib L; Ladraa S; Fraissenon A; Bayard C; Firpion M; Venot Q; Protic S; Hoguin C; Thomas A; Fraitag S; Duong JP; Kaltenbach S; Balducci E; Lefevre C; Villarese P; Asnafi V; Broissand C; Goudin N; Nemazanyy I; Autret G; Tavitian B; Legendre C; Arzouk N; Minard-Colin V; Chopinet C; Dussiot M; Adams DM; Mirault T; Guibaud L; Isenring P; Canaud G
Signal Transduct Target Ther; 2024 Jun; 9(1):146. PubMed ID: 38880808
[TBL] [Abstract][Full Text] [Related]
38. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
[TBL] [Abstract][Full Text] [Related]
39. PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA).
Hori Y; Hirose K; Ozeki M; Hata K; Motooka D; Tahara S; Matsui T; Kohara M; Higashihara H; Ono Y; Tanaka K; Toyosawa S; Morii E
Diagn Pathol; 2022 Jan; 17(1):19. PubMed ID: 35094709
[TBL] [Abstract][Full Text] [Related]
40. Functional assessment of two variants of unknown significance in TEK by endothelium-specific expression in zebrafish embryos.
Bell LM; Holm A; Matysiak U; Driever W; Rößler J; Schanze D; Wieland I; Niemeyer CM; Zenker M; Kapp FG
Hum Mol Genet; 2021 Dec; 31(1):10-17. PubMed ID: 34254124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
